Anetumab ravtansine, 1mg*5

Anetumab ravtansine, 1mg*5

Polatuzumab vedotin-piiq, 1mg*5

Polatuzumab vedotin-piiq, 1mg*5

Polatuzumab vedotin-piiq, 1mg

6.475,98 RON
SKU
SKM_D4012_1mg

Polatuzumab vedotin-piiq (polatuzumab vedotin, DCDS4501A, RG7596) is an antibody-drug conjugate (ADC) composed of a monoclonal antibody against CD79b(a B cell receptor component) and the anti-mitotic cytotoxic agent monomethyl auristatin (MMAE). It is used for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).

Mai multe informatii
Price 5.442,00 RON (preturile sunt fara TVA)
Description

Polatuzumab vedotin-piiq (polatuzumab vedotin, DCDS4501A, RG7596) is an antibody-drug conjugate (ADC) composed of a monoclonal antibody against CD79b(a B cell receptor component) and the anti-mitotic cytotoxic agent monomethyl auristatin (MMAE). It is used for the treatment of relapsed/refractory diffuse large B-cell lymphoma (DLBCL).